- Healthgen Biotech Wonderful memories at KSSCR International Symposium 2019 On September 26-28, 2019, the 3-days KSSCR International Symposium 2019 was successfully ended in Grand Hilton Seoul, South Korea. 2019 ISSCR/KSSCR International Symposium is a joint meeting of the Korean Society for Stem Cell Research (KSSCR) and th... Posted by Site editor|2019-10-08 LearnMore
- Healthgen Biotech will attend the World Advanced Therapies & Regenerative Medicine Congress 2019 in London, UK Date: 5/15/2019 - 5/17/2019 Venue: Business Design Centre Address: Business Design Centre Ltd,, 52 Upper St, London N1 0QH Booth No: #6 The World Advanced Therapies&Regenerative Medicine Congress is Europe’s most important advance... Posted by Site editor|2019-05-04 LearnMore
- [Breaking News] Healthgen Biotech has successfully completed the clinical trial Phase I of OsrHSA in the US Wuhan Healthgen Biotechnology Corp. (Healthgen Biotech) has completed the clinical trial phase I of plant-derived OsrHSA, Recombinant Human Serum Albumin (project No. HY1001), produced by the world’s first plant technology platform----OryzHiExp: rice endospe... Posted by Site editor|2020-03-31 LearnMore
- Recombinant Human Serum Albumin(OsrHSA) From Rice Was Approved By USA FDA For Clinical Study On August 10, 2019, Wuhan Healthgen Biotechnology Co., Ltd. received approval from the FDA of the United States for clinical trials on OsrHSA injection that was produced from rice expression platform. This is the first blood product from China which was approved for clinical tr... Posted by Site editor|2019-08-10 LearnMore
- Recombinant Human Serum Albumin(OsrHSA) Derived From Oryza Sativa Has Been Approved By CFDA For The Clinical Trial In China OsrHSA, a recombinant human serum albumin derived from transgenic rice seeds has gained the approval of the clinical trial from Chinese Food and Drug Administration (CFDA) at 28 April, 2017. It is a milestone event in the research and applications of plant bioreactor, which ... Posted by Site editor|2017-05-22 LearnMore
Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3